Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-046206
Filing Date
2021-07-09
Accepted
2021-07-09 17:08:24
Documents
1
Period of Report
2021-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3198
  Complete submission text file 0001209191-21-046206.txt   4548
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address
Hamm John M. (Reporting) CIK: 0001870439 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33637 | Film No.: 211083476